nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—SLC6A14—female reproductive system—ovarian cancer	0.00372	0.341	CbGeAlD
Valganciclovir—SLC15A1—epithelium—ovarian cancer	0.00126	0.116	CbGeAlD
Valganciclovir—SLC15A1—endometrium—ovarian cancer	0.00113	0.104	CbGeAlD
Valganciclovir—SLC15A1—vagina—ovarian cancer	0.000848	0.0777	CbGeAlD
Valganciclovir—SLC15A2—uterine cervix—ovarian cancer	0.000783	0.0717	CbGeAlD
Valganciclovir—SLC15A2—endometrium—ovarian cancer	0.000708	0.0648	CbGeAlD
Valganciclovir—Cough—Docetaxel—ovarian cancer	0.000626	0.000633	CcSEcCtD
Valganciclovir—Insomnia—Paclitaxel—ovarian cancer	0.000625	0.000632	CcSEcCtD
Valganciclovir—Pneumonia—Epirubicin—ovarian cancer	0.000623	0.00063	CcSEcCtD
Valganciclovir—Convulsion—Docetaxel—ovarian cancer	0.000622	0.000628	CcSEcCtD
Valganciclovir—Paraesthesia—Paclitaxel—ovarian cancer	0.00062	0.000627	CcSEcCtD
Valganciclovir—Hypertension—Docetaxel—ovarian cancer	0.000619	0.000626	CcSEcCtD
Valganciclovir—Infestation NOS—Epirubicin—ovarian cancer	0.000619	0.000626	CcSEcCtD
Valganciclovir—Infestation—Epirubicin—ovarian cancer	0.000619	0.000626	CcSEcCtD
Valganciclovir—Bronchitis—Doxorubicin—ovarian cancer	0.000618	0.000625	CcSEcCtD
Valganciclovir—Dyspnoea—Paclitaxel—ovarian cancer	0.000616	0.000623	CcSEcCtD
Valganciclovir—Somnolence—Paclitaxel—ovarian cancer	0.000614	0.000621	CcSEcCtD
Valganciclovir—Arthralgia—Docetaxel—ovarian cancer	0.000611	0.000618	CcSEcCtD
Valganciclovir—Pancytopenia—Doxorubicin—ovarian cancer	0.00061	0.000617	CcSEcCtD
Valganciclovir—Nausea—Vinorelbine—ovarian cancer	0.00061	0.000617	CcSEcCtD
Valganciclovir—Renal failure—Epirubicin—ovarian cancer	0.000609	0.000615	CcSEcCtD
Valganciclovir—Dyspepsia—Paclitaxel—ovarian cancer	0.000608	0.000615	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000607	0.000614	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000607	0.000613	CcSEcCtD
Valganciclovir—Stomatitis—Epirubicin—ovarian cancer	0.000604	0.00061	CcSEcCtD
Valganciclovir—Jaundice—Epirubicin—ovarian cancer	0.000604	0.00061	CcSEcCtD
Valganciclovir—Urinary tract infection—Epirubicin—ovarian cancer	0.000602	0.000609	CcSEcCtD
Valganciclovir—Dysuria—Doxorubicin—ovarian cancer	0.000601	0.000608	CcSEcCtD
Valganciclovir—Neutropenia—Doxorubicin—ovarian cancer	0.000601	0.000608	CcSEcCtD
Valganciclovir—Decreased appetite—Paclitaxel—ovarian cancer	0.000601	0.000607	CcSEcCtD
Valganciclovir—Dry mouth—Docetaxel—ovarian cancer	0.000597	0.000604	CcSEcCtD
Valganciclovir—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000597	0.000604	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000596	0.000603	CcSEcCtD
Valganciclovir—Fatigue—Paclitaxel—ovarian cancer	0.000596	0.000602	CcSEcCtD
Valganciclovir—Pollakiuria—Doxorubicin—ovarian cancer	0.000594	0.0006	CcSEcCtD
Valganciclovir—Pain—Paclitaxel—ovarian cancer	0.000591	0.000597	CcSEcCtD
Valganciclovir—Constipation—Paclitaxel—ovarian cancer	0.000591	0.000597	CcSEcCtD
Valganciclovir—Haematuria—Epirubicin—ovarian cancer	0.00059	0.000597	CcSEcCtD
Valganciclovir—Confusional state—Docetaxel—ovarian cancer	0.00059	0.000597	CcSEcCtD
Valganciclovir—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000587	0.000593	CcSEcCtD
Valganciclovir—SLC15A2—female reproductive system—ovarian cancer	0.000586	0.0537	CbGeAlD
Valganciclovir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000586	0.000592	CcSEcCtD
Valganciclovir—Anaphylactic shock—Docetaxel—ovarian cancer	0.000586	0.000592	CcSEcCtD
Valganciclovir—Oedema—Docetaxel—ovarian cancer	0.000586	0.000592	CcSEcCtD
Valganciclovir—Infection—Docetaxel—ovarian cancer	0.000582	0.000588	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—ovarian cancer	0.000581	0.000588	CcSEcCtD
Valganciclovir—Sinusitis—Epirubicin—ovarian cancer	0.000581	0.000587	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—ovarian cancer	0.00058	0.000586	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—ovarian cancer	0.000576	0.000583	CcSEcCtD
Valganciclovir—Nervous system disorder—Docetaxel—ovarian cancer	0.000574	0.000581	CcSEcCtD
Valganciclovir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000573	0.00058	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—ovarian cancer	0.000573	0.000579	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—ovarian cancer	0.000573	0.000579	CcSEcCtD
Valganciclovir—Tachycardia—Docetaxel—ovarian cancer	0.000571	0.000578	CcSEcCtD
Valganciclovir—Feeling abnormal—Paclitaxel—ovarian cancer	0.000569	0.000576	CcSEcCtD
Valganciclovir—Skin disorder—Docetaxel—ovarian cancer	0.000569	0.000575	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000565	0.000571	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—ovarian cancer	0.000563	0.000569	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000562	0.000568	CcSEcCtD
Valganciclovir—Haemoglobin—Epirubicin—ovarian cancer	0.000559	0.000565	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—ovarian cancer	0.000559	0.000565	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—ovarian cancer	0.000559	0.000565	CcSEcCtD
Valganciclovir—Anorexia—Docetaxel—ovarian cancer	0.000558	0.000564	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—ovarian cancer	0.000557	0.000563	CcSEcCtD
Valganciclovir—Hepatitis—Epirubicin—ovarian cancer	0.000556	0.000562	CcSEcCtD
Valganciclovir—Haemorrhage—Epirubicin—ovarian cancer	0.000556	0.000562	CcSEcCtD
Valganciclovir—Pharyngitis—Epirubicin—ovarian cancer	0.000552	0.000558	CcSEcCtD
Valganciclovir—Urinary tract disorder—Epirubicin—ovarian cancer	0.000549	0.000555	CcSEcCtD
Valganciclovir—Urticaria—Paclitaxel—ovarian cancer	0.000549	0.000555	CcSEcCtD
Valganciclovir—Oedema peripheral—Epirubicin—ovarian cancer	0.000548	0.000554	CcSEcCtD
Valganciclovir—Hypotension—Docetaxel—ovarian cancer	0.000547	0.000553	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—ovarian cancer	0.000546	0.000552	CcSEcCtD
Valganciclovir—Connective tissue disorder—Epirubicin—ovarian cancer	0.000546	0.000552	CcSEcCtD
Valganciclovir—Abdominal pain—Paclitaxel—ovarian cancer	0.000546	0.000552	CcSEcCtD
Valganciclovir—Body temperature increased—Paclitaxel—ovarian cancer	0.000546	0.000552	CcSEcCtD
Valganciclovir—Urethral disorder—Epirubicin—ovarian cancer	0.000545	0.000551	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000542	0.000548	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—ovarian cancer	0.000538	0.000543	CcSEcCtD
Valganciclovir—Visual impairment—Epirubicin—ovarian cancer	0.000536	0.000542	CcSEcCtD
Valganciclovir—SLC15A2—female gonad—ovarian cancer	0.000533	0.0489	CbGeAlD
Valganciclovir—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000533	0.000539	CcSEcCtD
Valganciclovir—SLC15A2—vagina—ovarian cancer	0.00053	0.0486	CbGeAlD
Valganciclovir—Insomnia—Docetaxel—ovarian cancer	0.00053	0.000535	CcSEcCtD
Valganciclovir—Paraesthesia—Docetaxel—ovarian cancer	0.000526	0.000532	CcSEcCtD
Valganciclovir—Dyspnoea—Docetaxel—ovarian cancer	0.000522	0.000528	CcSEcCtD
Valganciclovir—Somnolence—Docetaxel—ovarian cancer	0.000521	0.000526	CcSEcCtD
Valganciclovir—Eye disorder—Epirubicin—ovarian cancer	0.00052	0.000525	CcSEcCtD
Valganciclovir—Tinnitus—Epirubicin—ovarian cancer	0.000518	0.000524	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—ovarian cancer	0.000517	0.000523	CcSEcCtD
Valganciclovir—Cardiac disorder—Epirubicin—ovarian cancer	0.000516	0.000522	CcSEcCtD
Valganciclovir—Dyspepsia—Docetaxel—ovarian cancer	0.000515	0.000521	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—ovarian cancer	0.000514	0.00052	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—ovarian cancer	0.000514	0.00052	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—ovarian cancer	0.000511	0.000516	CcSEcCtD
Valganciclovir—Decreased appetite—Docetaxel—ovarian cancer	0.000509	0.000515	CcSEcCtD
Valganciclovir—Hypersensitivity—Paclitaxel—ovarian cancer	0.000509	0.000515	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000508	0.000514	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—ovarian cancer	0.000507	0.000512	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000506	0.000511	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000505	0.000511	CcSEcCtD
Valganciclovir—Fatigue—Docetaxel—ovarian cancer	0.000505	0.00051	CcSEcCtD
Valganciclovir—Angiopathy—Epirubicin—ovarian cancer	0.000504	0.00051	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—ovarian cancer	0.000504	0.00051	CcSEcCtD
Valganciclovir—Immune system disorder—Epirubicin—ovarian cancer	0.000502	0.000508	CcSEcCtD
Valganciclovir—Mediastinal disorder—Epirubicin—ovarian cancer	0.000501	0.000507	CcSEcCtD
Valganciclovir—Pain—Docetaxel—ovarian cancer	0.000501	0.000506	CcSEcCtD
Valganciclovir—Constipation—Docetaxel—ovarian cancer	0.000501	0.000506	CcSEcCtD
Valganciclovir—Chills—Epirubicin—ovarian cancer	0.000499	0.000504	CcSEcCtD
Valganciclovir—Arrhythmia—Epirubicin—ovarian cancer	0.000497	0.000502	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—ovarian cancer	0.000496	0.000501	CcSEcCtD
Valganciclovir—Asthenia—Paclitaxel—ovarian cancer	0.000496	0.000501	CcSEcCtD
Valganciclovir—Alopecia—Epirubicin—ovarian cancer	0.000491	0.000497	CcSEcCtD
Valganciclovir—Pruritus—Paclitaxel—ovarian cancer	0.000489	0.000494	CcSEcCtD
Valganciclovir—Mental disorder—Epirubicin—ovarian cancer	0.000487	0.000492	CcSEcCtD
Valganciclovir—Malnutrition—Epirubicin—ovarian cancer	0.000484	0.000489	CcSEcCtD
Valganciclovir—Feeling abnormal—Docetaxel—ovarian cancer	0.000483	0.000488	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—ovarian cancer	0.000481	0.000486	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—ovarian cancer	0.00048	0.000485	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000479	0.000484	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—ovarian cancer	0.000477	0.000483	CcSEcCtD
Valganciclovir—Flatulence—Epirubicin—ovarian cancer	0.000477	0.000482	CcSEcCtD
Valganciclovir—Tension—Epirubicin—ovarian cancer	0.000475	0.00048	CcSEcCtD
Valganciclovir—Dysgeusia—Epirubicin—ovarian cancer	0.000474	0.000479	CcSEcCtD
Valganciclovir—SLC15A2—testis—ovarian cancer	0.000473	0.0433	CbGeAlD
Valganciclovir—Diarrhoea—Paclitaxel—ovarian cancer	0.000473	0.000478	CcSEcCtD
Valganciclovir—Nervousness—Epirubicin—ovarian cancer	0.00047	0.000475	CcSEcCtD
Valganciclovir—Back pain—Epirubicin—ovarian cancer	0.000468	0.000473	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—ovarian cancer	0.000467	0.000472	CcSEcCtD
Valganciclovir—Muscle spasms—Epirubicin—ovarian cancer	0.000465	0.00047	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—ovarian cancer	0.000465	0.00047	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000464	0.000469	CcSEcCtD
Valganciclovir—Body temperature increased—Docetaxel—ovarian cancer	0.000463	0.000468	CcSEcCtD
Valganciclovir—Abdominal pain—Docetaxel—ovarian cancer	0.000463	0.000468	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—ovarian cancer	0.000462	0.000467	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—ovarian cancer	0.00046	0.000465	CcSEcCtD
Valganciclovir—Dizziness—Paclitaxel—ovarian cancer	0.000457	0.000462	CcSEcCtD
Valganciclovir—Vision blurred—Epirubicin—ovarian cancer	0.000456	0.000461	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—ovarian cancer	0.000455	0.00046	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—ovarian cancer	0.000451	0.000456	CcSEcCtD
Valganciclovir—Ill-defined disorder—Epirubicin—ovarian cancer	0.000449	0.000454	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—ovarian cancer	0.000448	0.000453	CcSEcCtD
Valganciclovir—Anaemia—Epirubicin—ovarian cancer	0.000447	0.000452	CcSEcCtD
Valganciclovir—Agitation—Epirubicin—ovarian cancer	0.000445	0.00045	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—ovarian cancer	0.000441	0.000446	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—ovarian cancer	0.000439	0.000444	CcSEcCtD
Valganciclovir—Vomiting—Paclitaxel—ovarian cancer	0.000439	0.000444	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—ovarian cancer	0.000438	0.000443	CcSEcCtD
Valganciclovir—Malaise—Epirubicin—ovarian cancer	0.000436	0.000441	CcSEcCtD
Valganciclovir—Dermatitis—Paclitaxel—ovarian cancer	0.000435	0.00044	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—ovarian cancer	0.000435	0.00044	CcSEcCtD
Valganciclovir—Vertigo—Epirubicin—ovarian cancer	0.000435	0.00044	CcSEcCtD
Valganciclovir—Leukopenia—Epirubicin—ovarian cancer	0.000433	0.000438	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—ovarian cancer	0.000433	0.000438	CcSEcCtD
Valganciclovir—Headache—Paclitaxel—ovarian cancer	0.000433	0.000438	CcSEcCtD
Valganciclovir—Hypersensitivity—Docetaxel—ovarian cancer	0.000431	0.000436	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—ovarian cancer	0.00043	0.000435	CcSEcCtD
Valganciclovir—Cough—Epirubicin—ovarian cancer	0.000422	0.000427	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—ovarian cancer	0.000422	0.000427	CcSEcCtD
Valganciclovir—Asthenia—Docetaxel—ovarian cancer	0.00042	0.000425	CcSEcCtD
Valganciclovir—Convulsion—Epirubicin—ovarian cancer	0.000419	0.000424	CcSEcCtD
Valganciclovir—Hypertension—Epirubicin—ovarian cancer	0.000418	0.000422	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000415	0.00042	CcSEcCtD
Valganciclovir—Pruritus—Docetaxel—ovarian cancer	0.000414	0.000419	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—ovarian cancer	0.000414	0.000418	CcSEcCtD
Valganciclovir—Arthralgia—Epirubicin—ovarian cancer	0.000412	0.000417	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—ovarian cancer	0.000411	0.000416	CcSEcCtD
Valganciclovir—Anxiety—Epirubicin—ovarian cancer	0.000411	0.000415	CcSEcCtD
Valganciclovir—Nausea—Paclitaxel—ovarian cancer	0.00041	0.000415	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000409	0.000414	CcSEcCtD
Valganciclovir—Discomfort—Epirubicin—ovarian cancer	0.000407	0.000412	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—ovarian cancer	0.000404	0.000408	CcSEcCtD
Valganciclovir—Dry mouth—Epirubicin—ovarian cancer	0.000403	0.000407	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—ovarian cancer	0.000402	0.000407	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—ovarian cancer	0.000401	0.000405	CcSEcCtD
Valganciclovir—Diarrhoea—Docetaxel—ovarian cancer	0.000401	0.000405	CcSEcCtD
Valganciclovir—Confusional state—Epirubicin—ovarian cancer	0.000398	0.000403	CcSEcCtD
Valganciclovir—Anaphylactic shock—Epirubicin—ovarian cancer	0.000395	0.000399	CcSEcCtD
Valganciclovir—Oedema—Epirubicin—ovarian cancer	0.000395	0.000399	CcSEcCtD
Valganciclovir—Infection—Epirubicin—ovarian cancer	0.000392	0.000397	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—ovarian cancer	0.000391	0.000395	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—ovarian cancer	0.000388	0.000392	CcSEcCtD
Valganciclovir—Nervous system disorder—Epirubicin—ovarian cancer	0.000387	0.000392	CcSEcCtD
Valganciclovir—Dizziness—Docetaxel—ovarian cancer	0.000387	0.000391	CcSEcCtD
Valganciclovir—Thrombocytopenia—Epirubicin—ovarian cancer	0.000387	0.000391	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—ovarian cancer	0.000387	0.000391	CcSEcCtD
Valganciclovir—Tachycardia—Epirubicin—ovarian cancer	0.000385	0.00039	CcSEcCtD
Valganciclovir—Skin disorder—Epirubicin—ovarian cancer	0.000384	0.000388	CcSEcCtD
Valganciclovir—Hyperhidrosis—Epirubicin—ovarian cancer	0.000382	0.000386	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—ovarian cancer	0.000381	0.000385	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—ovarian cancer	0.00038	0.000384	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000379	0.000383	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—ovarian cancer	0.000377	0.000381	CcSEcCtD
Valganciclovir—Anorexia—Epirubicin—ovarian cancer	0.000376	0.000381	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—ovarian cancer	0.000373	0.000377	CcSEcCtD
Valganciclovir—Vomiting—Docetaxel—ovarian cancer	0.000372	0.000376	CcSEcCtD
Valganciclovir—Hypotension—Epirubicin—ovarian cancer	0.000369	0.000373	CcSEcCtD
Valganciclovir—Dermatitis—Docetaxel—ovarian cancer	0.000369	0.000373	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—ovarian cancer	0.000368	0.000373	CcSEcCtD
Valganciclovir—Headache—Docetaxel—ovarian cancer	0.000367	0.000371	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—ovarian cancer	0.000365	0.000369	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000365	0.000369	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—ovarian cancer	0.000363	0.000367	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00036	0.000364	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—ovarian cancer	0.000358	0.000362	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000358	0.000362	CcSEcCtD
Valganciclovir—Insomnia—Epirubicin—ovarian cancer	0.000357	0.000361	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—ovarian cancer	0.000357	0.000361	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—ovarian cancer	0.000355	0.000359	CcSEcCtD
Valganciclovir—Paraesthesia—Epirubicin—ovarian cancer	0.000355	0.000359	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000353	0.000357	CcSEcCtD
Valganciclovir—Dyspnoea—Epirubicin—ovarian cancer	0.000352	0.000356	CcSEcCtD
Valganciclovir—Somnolence—Epirubicin—ovarian cancer	0.000351	0.000355	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—ovarian cancer	0.000348	0.000352	CcSEcCtD
Valganciclovir—Nausea—Docetaxel—ovarian cancer	0.000348	0.000352	CcSEcCtD
Valganciclovir—Dyspepsia—Epirubicin—ovarian cancer	0.000348	0.000351	CcSEcCtD
Valganciclovir—Decreased appetite—Epirubicin—ovarian cancer	0.000343	0.000347	CcSEcCtD
Valganciclovir—SLC15A2—lymph node—ovarian cancer	0.000343	0.0314	CbGeAlD
Valganciclovir—Hypotension—Doxorubicin—ovarian cancer	0.000341	0.000345	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000341	0.000345	CcSEcCtD
Valganciclovir—Fatigue—Epirubicin—ovarian cancer	0.000341	0.000344	CcSEcCtD
Valganciclovir—Pain—Epirubicin—ovarian cancer	0.000338	0.000341	CcSEcCtD
Valganciclovir—Constipation—Epirubicin—ovarian cancer	0.000338	0.000341	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000333	0.000337	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—ovarian cancer	0.000331	0.000334	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—ovarian cancer	0.000328	0.000332	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—ovarian cancer	0.000326	0.000329	CcSEcCtD
Valganciclovir—Feeling abnormal—Epirubicin—ovarian cancer	0.000325	0.000329	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—ovarian cancer	0.000325	0.000328	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000323	0.000327	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—ovarian cancer	0.000322	0.000325	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—ovarian cancer	0.000318	0.000321	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000315	0.000319	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—ovarian cancer	0.000315	0.000319	CcSEcCtD
Valganciclovir—Urticaria—Epirubicin—ovarian cancer	0.000314	0.000317	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—ovarian cancer	0.000313	0.000316	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—ovarian cancer	0.000313	0.000316	CcSEcCtD
Valganciclovir—Abdominal pain—Epirubicin—ovarian cancer	0.000312	0.000316	CcSEcCtD
Valganciclovir—Body temperature increased—Epirubicin—ovarian cancer	0.000312	0.000316	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—ovarian cancer	0.000301	0.000304	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000299	0.000302	CcSEcCtD
Valganciclovir—Hypersensitivity—Epirubicin—ovarian cancer	0.000291	0.000294	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—ovarian cancer	0.00029	0.000294	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—ovarian cancer	0.000289	0.000292	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—ovarian cancer	0.000289	0.000292	CcSEcCtD
Valganciclovir—Asthenia—Epirubicin—ovarian cancer	0.000283	0.000286	CcSEcCtD
Valganciclovir—Pruritus—Epirubicin—ovarian cancer	0.000279	0.000283	CcSEcCtD
Valganciclovir—Diarrhoea—Epirubicin—ovarian cancer	0.00027	0.000273	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—ovarian cancer	0.000269	0.000272	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—ovarian cancer	0.000262	0.000265	CcSEcCtD
Valganciclovir—Dizziness—Epirubicin—ovarian cancer	0.000261	0.000264	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—ovarian cancer	0.000259	0.000261	CcSEcCtD
Valganciclovir—Vomiting—Epirubicin—ovarian cancer	0.000251	0.000254	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—ovarian cancer	0.00025	0.000253	CcSEcCtD
Valganciclovir—Dermatitis—Epirubicin—ovarian cancer	0.000249	0.000252	CcSEcCtD
Valganciclovir—Headache—Epirubicin—ovarian cancer	0.000247	0.00025	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—ovarian cancer	0.000242	0.000244	CcSEcCtD
Valganciclovir—Nausea—Epirubicin—ovarian cancer	0.000235	0.000237	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—ovarian cancer	0.000232	0.000235	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—ovarian cancer	0.00023	0.000233	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—ovarian cancer	0.000229	0.000231	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—ovarian cancer	0.000217	0.000219	CcSEcCtD
